WO2023148525 - 2'-FUCOSYLLACTOSE AND LACTO-N-NEOTETRAOSE FOR PREVENTING AND TREATING OVERWEIGHT
National phase entry:
Publication Number
WO/2023/148525
Publication Date
10.08.2023
International Application No.
PCT/IB2022/050979
International Filing Date
04.02.2022
Title **
[English]
2'-FUCOSYLLACTOSE AND LACTO-N-NEOTETRAOSE FOR PREVENTING AND TREATING OVERWEIGHT
[French]
2'-FUCOSYLLACTOSE ET LACTO-N-NÉOTÉTRAOSE POUR PRÉVENIR ET TRAITER LE SURPOIDS
Applicants **
HEALTH AND HAPPINESS (H&H) HONG KONG LTD
Inventors
JONATHAN, Lane
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1571 | |
| EPO | Filing, Examination, Granting | 11458 | |
| Japan | Filing, Examination, Granting | 2122 | |
| South Korea | Filing, Examination, Granting | 1893 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,784
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
It relates to the use of 2 '-fucosyllactose and Lacto-N-neotetraose for treating and/or reducing weight in a subject in need thereof. It also relates to pharmaceutical and food compositions containing these compounds.[French]
L'invention concerne l'utilisation de 2'-fucosyllactose et de lacto-N-néotétraose pour traiter et/ou réduire le poids d'un sujet le nécessitant. L'invention concerne également des compositions pharmaceutiques et alimentaires contenant ces composés.